The two Republican Commissioners voted no and dissented from approving the Policy Statement, citing concerns about improperly expanding the scope of the HBNR outside of the rulemaking process and depriving the public of the opportunity to comment on agency rulemaking.
In her dissenting statement, Commissioner Christine S. Wilson noted that the Policy Statement contradicts existing FTC business guidance and curtails an open, ongoing rulemaking process that covers the HBNR.
In his dissenting statement, Commissioner Noah Joshua Phillips echoed the same concerns and further noted that the HBNR provides an unworkable “remedy” for notice of a breach in the context of apps and companies that operate based on the sharing of health-related consumer data.
Related: New FTC Policies Restore Prior Approval Policy For Merger
The Commission signaled its intent to bring actions to enforce the HBNR consistent with the Policy Statement. However, there could be meaningful challenges to this purported clarification if the Commission seeks to enforce the HBNR against health-related apps and devices in the future.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Microsoft Faces EU Antitrust Charges Over Teams Software
May 13, 2024 by
CPI
EU Antitrust Complaint Filed Against Edwards Lifesciences by Indian Rival Meril
May 13, 2024 by
CPI
South Korea’s Antitrust Watchdog Partners with AliExpress and Temu to Address Safety Concerns
May 13, 2024 by
CPI
EU Designates Booking.com as ‘Gatekeeper’ Under Digital Markets Act
May 13, 2024 by
CPI
US Airlines Challenge Biden Administration Over New Airfare Fee Disclosure Rule
May 13, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI